IKS Health confirms talks held with TruBridge

In a notice to the BSE Limited, IKS Health stated: “This is with reference to your email dated April 13, 2026 seeking clarification on the news item published on April 13, 2026 in The Economic Times. We would like to clarify that the Company regularly evaluates strategic opportunities in the ordinary course of business, including bidding for potential strategic transactions through its subsidiaries, with or without exclusivity, such as in the captioned news. In furtherance to the foregoing, one of the wholly owned subsidiaries of the Company participated in discussions with TruBridge (TBRG), Inc. in relation to a potential acquisition of TruBridge. As on date, no definitive or binding agreements have been executed for such potential transaction. The aforesaid discussions remain non-binding and are subject to various contingencies, including ongoing negotiations, requisite approvals (including board approvals) and execution of definitive agreements. There can be no assurance that any transaction will be consummated or as to the terms or timing thereof. The Company will make appropriate disclosures only as and when there are material developments requiring disclosure under the applicable regulations.”